Trial Comparing CPDMA Versus Standard Breadloafing in WLE Specimens of Stage 1-II Cutaneous Melanoma | MicrobiomeTrials← Back to trialsNCT07869381
Trial Comparing CPDMA Versus Standard Breadloafing in WLE Specimens of Stage 1-II Cutaneous Melanoma
RecruitingNAINTERVENTIONAL
Trial Details
Start: 2026-12-24Est. Completion: 2029-12-24
Enrollment target: 282 participants Locations- University of Nebraska Medical Center, Omaha, Nebraska, United States
Other microbiome trials you might be interested in
Pathologic Stage I Cutaneous Merkel Cell Carcinoma AJCC v8Pathologic Stage II Cutaneous Merkel Cell Carcinoma AJCC v8Pathologic Stage III Cutaneous Merkel Cell Carcinoma AJCC v8
This phase III trial studies how well pembrolizumab works compared to standard of care observation in treating patients …
Birmingham, United StatesEst. completion Dec 31, 2026
Acral Lentiginous MelanomaClinical Stage III Cutaneous Melanoma AJCC v8Clinical Stage IV Cutaneous Melanoma AJCC v8
Mucosal Melanoma
This phase II trial studies how pembrolizumab works before and after surgery in treating patients with stage III-IV high…
Birmingham, United StatesEst. completion Sep 1, 2022
Stage III Cutaneous Melanoma AJCC v7Stage IV Cutaneous Melanoma AJCC v6 and v7
This phase II/III trial studies the side effects of nivolumab and ipilimumab when given together with or without sargram…
Birmingham, United StatesEst. completion Jun 30, 2033